1
Publications
0
Followers
0
Following
0
Questions
About
Dr. Shubhra Medhashri Mishra, a PhD holder from Barkatullah University, specializes in medical content writing and research, focusing on oncology and pharmaceutical sciences. With extensive experience as Lead Medical Content Writer at Mind Digital Group and Technical Research Analysis Editor at i mStarLex Managed Solution, she excels in clinical trial reports, manuscript preparation, and oncology congress presentations. Her research on the anticancer properties of flavonoids from Euphorbia hirta has been published in prestigious journals and presented at international conferences. Dr. Mishra's skills include MTT assay, GC-MS, HPLC, and she has received awards for her contributions to pharmaceutical research and presentation excellence.
Skills & Expertise
HPLC
Applied Chemistry
Chem Biology
Pharmaceutical Analysis
GC-MS
Water Analysis Techniques
Research Interests
RESEARCH
Content Writer
Technical Research Analysis
Connect With Me
Experience
- • Product Dossier Preparations, Designed Health supplements and their formulation as per international regulatory standards, clinical and non-clinical summary, • Preparation of Clinical Trial reports, publications in PubMed, CSR narratives, information brochure, leaflets • Medical Content Writing and Healthcare Blogs • Acquiring Clinical Trials data and analysis • Worked with CRO consultancies • Product Mapping and Claims • Design of product listing page, and other website pages for products • Market Search & Competition Analysis • Medico Marketing • Coordination with external stakeholders
Education
Barkatullah University
Projects
Submitted report on study of ACE-inhibitors focusing mainly on Lisinopril during dissertation
Conferences & Seminars (1)
Computer Aided Drug Design
No descriptions
Thesis Guided (1)
Anticancer Activity of Flavonoids from Euphorbia hirta On Human Melanoma cell l ines
Institution: Barkatullah University
Publications (1)
Background
The most common subtypes of bone sarcomas are osteosarcoma and Ewing sarcoma. They are rare and heterogeneous form of cancers of mainly mesenchymal origin. Neo-adjuvant chemotherapy follow...
dd